Notice of intent Fluorodeoxyglucose (FDG)

Vestre Viken wants to enter into agreement with GE Healthcare Pharaceutical Diagnostics for the procurement of FDG for Nucleær Vestre Viken wants to enter into agreement with GE Healthcare Pharaceutical Diagnostics for the procurement of FDG for Nucleær

CPV: 33100000 Equipamento médico, 33600000 Produtos farmacêuticos
Local de execução:
Notice of intent Fluorodeoxyglucose (FDG)
Local de premiação:
Vestre Viken HF
Número do prémio:
25/05359

1. Buyer

1.1 Buyer

Official name : Vestre Viken HF

2. Procedure

2.1 Procedure

Title : Notice of intent Fluorodeoxyglucose (FDG)
Description : Vestre Viken wants to enter into agreement with GE Healthcare Pharaceutical Diagnostics for the procurement of FDG for Nucleær
Procedure identifier : 3f1ac8a1-fd29-47a7-976f-5c7e74a33ec9
Internal identifier : 25/05359
Type of procedure : Negotiated without prior call for competition

2.1.1 Purpose

Main nature of the contract : Supplies
Main classification ( cpv ): 33600000 Pharmaceutical products
Additional classification ( cpv ): 33100000 Medical equipments

2.1.2 Place of performance

Postal address : Drammen Sykehus
Town : Drammen
Postcode : 3015
Country subdivision (NUTS) : Buskerud ( NO085 )
Country : Norway

2.1.4 General information

Legal basis :
Directive 2014/24/EU
Anskaffelsesforskriften - There are no alternative suppliers who can offer the same product. FDG is essential for diagnosing and treating patients, and continual access is necessary to maintain the hospital's services. In accordance with the public procurement regulations § 21-5, we have the right to enter into this contract without announcing the competition.

5. Lot

5.1 Lot technical ID : LOT-0000

Title : Notice of intent Fluorodeoxyglucose (FDG)
Description : Vestre Viken wants to enter into agreement with GE Healthcare Pharaceutical Diagnostics for the procurement of FDG for Nucleær
Internal identifier : 25/05359

5.1.1 Purpose

Main nature of the contract : Supplies
Main classification ( cpv ): 33600000 Pharmaceutical products
Additional classification ( cpv ): 33100000 Medical equipments
Quantity : 100 piece

5.1.2 Place of performance

Postal address : Drammen Sykehus
Town : Drammen
Postcode : 3015
Country subdivision (NUTS) : Buskerud ( NO085 )
Country : Norway
Additional information :

5.1.3 Estimated duration

Start date : 01/10/2025
Duration end date : 30/09/2027

5.1.4 Renewal

Maximum renewals : 2
Other information about renewals : Automatic extension for 1+1 year.

5.1.6 General information

Procurement Project not financed with EU Funds.
The procurement is covered by the Government Procurement Agreement (GPA) : no

5.1.16 Further information, mediation and review

Mediation organisation : Buskerud Tingrett -
Review organisation : Buskerud Tingrett -
Information about review deadlines : 10 days from the notice
Organisation providing more information on the review procedures : Vestre Viken HF -
Organisation whose budget is used to pay for the contract : Vestre Viken HF
Organisation executing the payment : Vestre Viken HF
Organisation signing the contract : Vestre Viken HF

6. Results

Value of all contracts awarded in this notice : 32 000 000 Norwegian krone
Direct award :
Justification for direct award : The contract can be provided only by a particular economic operator because of an absence of competition for technical reasons
Other justification : We plan to enter into a contract with GE Healthcare AS for the delivery of FDG (Fluorodeoxyglucose) without holding a normal tender contest. The basis for this notice of intent is as follows: - Only supplier: GE Healthcare AS is the only supplier of FDG in Norway and there are no alternative suppliers who can offer the same product. - Critical need: FDG is essential for diagnosing and treatment of patients, and continual access is necessary to maintain the hospital's services. Time sensitivity: Due to the acute need for FDG, it is not practical to hold a full tender contest that can delay delivery. Legal basis: In accordance with the public procurement regulations § 21-5, we intend to enter into this contract directly with GE Healthcare AS without announcing the competition.

6.1 Result lot ldentifier : LOT-0000

6.1.2 Information about winners

Winner :
Official name : GE HealthCare Pharmaceutical Diagnostics (PDx)
Tender :
Tender identifier : 25/05359
Identifier of lot or group of lots : LOT-0000
Value of the tender : 32 000 000 Norwegian krone
The tender was ranked : no
Subcontracting : No
Contract information :
Identifier of the contract : 25/05359
Title : RA Framework agreement F18 FDG (SteriPET)
Date on which the winner was chosen : 12/05/2025
Organisation signing the contract : Vestre Viken HF

8. Organisations

8.1 ORG-0001

Official name : Vestre Viken HF
Registration number : 894166762
Postal address : Grønland 32
Town : DRAMMEN
Postcode : 3045
Country subdivision (NUTS) : Buskerud ( NO085 )
Country : Norway
Contact point : Kjell Runar Moen
Telephone : +4795528288
Internet address : http://www.vestreviken.no
Roles of this organisation :
Buyer
Organisation providing more information on the review procedures
Organisation signing the contract
Organisation whose budget is used to pay for the contract
Organisation executing the payment

8.1 ORG-0002

Official name : GE HealthCare Pharmaceutical Diagnostics (PDx)
Size of the economic operator : Large
Registration number : 914829674
Town : Oslo
Postcode : 0401
Country subdivision (NUTS) : Oslo ( NO081 )
Country : Norway
Roles of this organisation :
Tenderer
Winner of these lots : LOT-0000
The winner is listed on a regulated market

8.1 ORG-0003

Official name : Buskerud Tingrett
Registration number : 826 726 342
Town : Drammen
Postcode : 3003
Country subdivision (NUTS) : Buskerud ( NO085 )
Country : Norway
Roles of this organisation :
Review organisation
Mediation organisation
Notice information
Notice identifier/version : 8924a62b-8537-4ba4-9fe9-eaffd65edd0c - 01
Form type : Direct award preannouncement
Notice type : Voluntary ex-ante transparency notice
Notice dispatch date : 12/05/2025 08:05 +00:00
Notice dispatch date (eSender) : 12/05/2025 08:17 +00:00
Languages in which this notice is officially available : English
Notice publication number : 00303824-2025
OJ S issue number : 91/2025
Publication date : 13/05/2025